研究業績RESEARCH ACHIEVEMENT
柄山先生の研究成果がCancer Immunology, Immunotherapyに掲載されました。
呼吸器内科
2022.03.16
Karayama M, Inui N, Inoue Y, Yoshimura K, Mori K, Hozumi H, Suzuki Y, Furuhashi K, Fujisawa T, Enomoto N, Nakamura Y, Asada K, Uto T, Fujii M, Matsui T, Matsuura S, Hashimoto D, Toyoshima M, Kusagaya H, Matsuda H, Inami N, Kaida Y, Niwa M, Ito Y, Suda T. Increased serum cholesterol and long-chain fatty acid levels are associated with the efficacy of nivolumab in patients with non-small cell lung cancer. Cancer Immunol Immunother. 2022 Jan;71(1):203-217. doi: 10.1007/s00262-021-02979-4. Epub 2021 Jun 5. PMID: 34091744; PMCID: PMC8738455.